| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2006 | CN1238053C Medicine composition containing alfa-interferon , lamivudine and adefovir |
| 01/25/2006 | CN1238050C Traditional Chinese medicinal paste for treating arthralgia-syndrome and preparation method thereof |
| 01/25/2006 | CN1238048C Chinese traditional medicine for treating arthralgia -syndrome and its preparation |
| 01/25/2006 | CN1238035C Medicine for treating tuberculosis and its preparing process |
| 01/25/2006 | CN1238032C Tincture for curing acne and preparation method |
| 01/25/2006 | CN1238029C Decoction for treating cardiovascular and cerebrovascular disease |
| 01/25/2006 | CN1238025C Preparation method of traumatic injury bone-setting plaster |
| 01/25/2006 | CN1238019C Oil for comforting channels and collaterals |
| 01/25/2006 | CN1238008C Medicine or function food for promoting human lead discharge and preparing method thereof |
| 01/25/2006 | CN1237997C Separating and purifying production process of proanthocyanidin oligomer from haw |
| 01/25/2006 | CN1237994C Medicine composition for treating ulcer and preparing method thereof |
| 01/25/2006 | CN1237993C Hyperosteogeny adhesive plaster and its preparation technology |
| 01/25/2006 | CN1237987C Capsul for curing pain due to hyperosteogeny and osteoarthritis disease and its preparation method |
| 01/25/2006 | CN1237983C Compound dryopteris rhizome aspirin tablet |
| 01/25/2006 | CN1237978C Composite eye-moistening liquid and its application |
| 01/25/2006 | CN1237977C Pepsin inhibition by alginates |
| 01/25/2006 | CN1237976C Bite spiramycin and its use in anti inflammatory disease |
| 01/25/2006 | CN1237975C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 01/25/2006 | CN1237974C Ursolic acid dripping pills and its preparation process |
| 01/25/2006 | CN1237973C Chronic bronchitis treating traditional Chinese medicine |
| 01/25/2006 | CN1237972C Active component of muskrat fragrant, preparing technique and usage |
| 01/25/2006 | CN1237971C Compound hypotension preparation containing angiotonin converzyme inhibitor, calcium ion antagonist and Estazolam |
| 01/25/2006 | CN1237970C Inhalant containing tiotropium salt solution |
| 01/25/2006 | CN1237969C Remedial agent for chronic articular rheumatism |
| 01/25/2006 | CN1237968C Methods for inhibiting proliferation and inducing apoptosis of cancer cells |
| 01/25/2006 | CN1237967C External use of indomethacin for treating cutaneous pruritus |
| 01/25/2006 | CN1237966C Compound hypotension preparation |
| 01/25/2006 | CN1237965C Oral disintegrating tablet of bambuterol hydrochloride and its preparation method |
| 01/25/2006 | CN1237964C Method for preparing granules containing brufen arginine composition |
| 01/25/2006 | CN1237963C Garlimax concentrated solution for intravenous injection after composite solvent dilution |
| 01/25/2006 | CN1237962C Pharmaceutical use of asafoetide extract |
| 01/25/2006 | CN1237961C Use of diphenyl ethylene-like compounds in preparing medicaments for treating and preventing diabetes or diseases associated with retrovirus |
| 01/25/2006 | CN1237960C Preparation method of aspirin microsphere |
| 01/25/2006 | CN1237959C Process for preparing pharmaceutical compositions for use with soft capsule |
| 01/25/2006 | CN1237958C Drug tablet composition of non slow-release and chewing |
| 01/25/2006 | CN1237957C Hypocrellin liposome solid powder preparaton and producing method |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989451 Substituted isothiazole compounds are useful for treating the diseases associated with abnormality in protein kinases(especially MAP kinases) |
| 01/24/2006 | US6989450 Aldol condensation of a ketonic compound containing free or protected alcohol group with a acid or or metallic salt group containing compound to form intermediate, performing macrolactonizing of the intermediate |
| 01/24/2006 | US6989448 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
| 01/24/2006 | US6989447 Compounds |
| 01/24/2006 | US6989445 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| 01/24/2006 | US6989443 Carboranylporphyrins and uses thereof |
| 01/24/2006 | US6989435 Compounds and methods to inhibit or augment an inflammatory response |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/24/2006 | US6989400 Treatment of benign prostatic hyperplasia |
| 01/24/2006 | US6989399 Antiamyloid phenylsulfonamides: N-alkanol derivatives |
| 01/24/2006 | US6989398 Benzanilides as potassium channel openers |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989396 Anticancer agents; modulating glycoprotein |
| 01/24/2006 | US6989395 TNF inhibitors |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989392 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
| 01/24/2006 | US6989391 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 01/24/2006 | US6989390 of carboxylic acids, such as maleic or glycolic acid; treating breast cancer, colon cancer, lung cancer, renal cancer and prostate cancer. |
| 01/24/2006 | US6989389 Immunomodulators; tetrahydroimidazo[4,5-c]quinoline-4-amine-1-(alkynyloxyalkyl) derivatives; induce cytokines biosynthesis; antitumor agents, viral diseases |
| 01/24/2006 | US6989388 Antitumor agents; anticancer agents; antiischemic agents; antiinflamamtory agents |
| 01/24/2006 | US6989387 Topoisomerase inhibitors; use treating cancer, as antifungal agent, treating bacterial infections; compounds based on Dibenzo[c,h][1,6]Naphthyridine ring with at least one nitro or amine-based substitution |
| 01/24/2006 | US6989386 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/24/2006 | US6989382 Enzyme inhibitors; pyridin-2-yl-amino-ethyl-amino-phenyl derivatives; diabetes, Alzheimer's disease, Parkinson's disease, Huntington's disease, obesity, cardiovascular disease, hypertension, polycystic ovary syndrome, ischemia, brain injury |
| 01/24/2006 | US6989381 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 01/24/2006 | US6989380 Treatment of pain |
| 01/24/2006 | US6989379 Selective NPY (Y5) antagonists |
| 01/24/2006 | US6989378 novel androgen (7 alpha ,17 beta )-7-methyl-17-[(1-oxoundecyl)oxy]estr-4en-3one); oil solubility; suitable for administration by means of injection; for male contraception |
| 01/24/2006 | US6989377 Treating vitamin D responsive diseases |
| 01/24/2006 | US6989376 Nervous system disorders; administering exogenous uridine compound |
| 01/24/2006 | US6989373 By injecting a biocompatible solution, with a given intrinsic viscosity, similar to a fatty acid mixture normally present in a healthy fat pad; treating heel pain |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | US6989368 Use of calmodulin to promote bone regeneration |
| 01/24/2006 | US6989364 treatment extends to all stages of progression of cardiac hypertrophy, with or without structural damage of the heart muscle, regardless of the underlying cardiac disorder |
| 01/24/2006 | US6989362 Methods of treating dopamine dysregulation using agents that regulate phosphorylation/dephosphorylation in dopamine signaling |
| 01/24/2006 | US6989275 Generating luminescent particles; generate reaction mixture containing biopolymers and cyanine dye, conjugate cyanine dye with biopolymer, evaluate signal from conjugate |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989166 Soft drink replacer |
| 01/24/2006 | US6989164 Mixture of carnitine, ferulic acid and vitamins |
| 01/24/2006 | US6989163 Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol |
| 01/24/2006 | US6989162 Hepatoprotective agent of plant origin and a process thereof |
| 01/24/2006 | US6989161 Mixture of lycopene, lutein, ellagic acid, quercetin, hesperidin andepigallocatechin |
| 01/24/2006 | US6989158 Gold-containing chemotherapeutic agents |
| 01/24/2006 | US6989157 Microbiocides; bactericides; antiinflammatory agents; fungicides; viricides |
| 01/24/2006 | US6989155 Particles comprising amino acid such as leucine and optionally with drug mixtures formed by aerosol condensation or spray drying, for use as inhalants; antiasthmatics |
| 01/24/2006 | US6989150 Cosmetic preparation of active substances with a synergistically increased radical protection factor |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989139 Matrix metalloproteinase inhibitors |
| 01/24/2006 | US6988619 Medicinal product package for eradication therapy |
| 01/24/2006 | US6988613 Composition for IVF |
| 01/24/2006 | CA2433366C Amlodipine free base |
| 01/24/2006 | CA2386828C Novel pseudoerythromycin derivatives |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/24/2006 | CA2347117C Methods for inhibiting diabetic complications |
| 01/24/2006 | CA2339353C Fast dissolving orally consumable films |
| 01/24/2006 | CA2292984C Ccr5 modulators |
| 01/24/2006 | CA2261923C Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 01/24/2006 | CA2255824C Nitrate esters and their use for neurological conditions |
| 01/24/2006 | CA2255447C Percutaneous absorption type preparation |
| 01/24/2006 | CA2238864C Method for the synthesis of a benzimidazole compound |